Bill Miller Organon & Co. Transaction History

Miller Value Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $829,500 - $1.19 Million	50,000 Added 22.52%	272,000 $4.72 Billion
Q2 2023 Aug 14, 2023	SELL	$19.27 - $24.63 $154,160 - $197,040	-8,000 Reduced 3.48%	222,000 $4.62 Billion
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $582,750 - $715,250	25,000 Added 12.2%	230,000 $6.43 Million
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $234,000 - $342,500	-10,000 Reduced 4.65%	205,000 $4.8 Million
Q2 2022 Aug 15, 2022	BUY	$31.66 - $38.9 $1.11 Million - $1.36 Million	35,000 Added 19.44%	215,000 $7.26 Million
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $716,750 - $928,250	25,000 Added 16.13%	180,000 $5.48 Million
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $4.44 Million - $5.52 Million	155,000 New	155,000 $5.08 Million

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Miller Value Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Miller Value Partners, LLC and Bill Miller with notifications on news.